β1,4-galactosyltransferase V. A growth regulator in glioma

Methods in Enzymology

Volumn 479, Issue C, 2010, Pages 3-23

  Jiang, Jianhai ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE V; GALACTOSYLTRANSFERASE; GLYCOPROTEIN; LECTIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; BETA-1,4-GALACTOSYLTRANSFERASE V;

BOOK; CANCER CELL CULTURE; CELL MIGRATION; CELL SURVIVAL; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; GROWTH REGULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL; ARTICLE; BRAIN TUMOR; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; GALACTOSYLTRANSFERASES; GLIOMA; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77956194160     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)79001-7     Document Type: Chapter

References (27)

1. Arato-Ohshima T., Sawa H. Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int. J. Cancer 1999, 83:387-392.
2. Bacon C.L., et al. Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase. J. Neurochem. 2002, 83:12-19.
3. Bergstrom J.D., et al. Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells. Exp. Cell Res. 2000, 259:293-299.
4. Chumsri S., Burger A.M. Cancer stem cell targeted agents: Therapeutic approaches and consequences. Curr. Opin. Mol. Ther. 2008, 10:323-333.
5. Das S., et al. Cancer stem cells and glioma. Nat. Clin. Pract. Neurol. 2008, 4:427-435.
6. Fan Q.W., et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 2006, 9:341-349.
7. Fan X., et al. Glioma stem cells: Evidence and limitation. Semin. Cancer Biol. 2007, 17:214-218.
8. Fine H.A. Glioma stem cells: Not all created equal. Cancer Cell 2009, 15:247-249.
9. Giese A., Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996, 39:235-250. (discussion 250-252).
10. Guo S., et al. Galactosylation of N-linked oligosaccharides by human beta-1, 4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 2001, 11:813-820.
11. Hambardzumyan D., et al. Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev. 2008, 4:203-210.
12. Jiang J., et al. beta1, 4-galactosyltransferase V functions as a positive growth regulator in glioma. J. Biol. Chem. 2006, 281:9482-9489.
13. Jiang J., et al. Functional interaction of E1AF and Sp1 in glioma invasion. Mol. Cell. Biol. 2007, 27:8770-8782.
14. Kurose K., et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am. J. Pathol. 2001, 158:2097-2106.
15. Nagane M., et al. Expression pattern of chemoresistance-related genes in human malignant brain tumors: A working knowledge for proper selection of anticancer drugs. Jpn. J. Clin. Oncol. 1999, 29:527-534.
16. Park C.Y., et al. Cancer stem cell-directed therapies: Recent data from the laboratory and clinic. Mol. Ther. 2009, 17:219-230.
17. Sato T., Furukawa K. Transcriptional regulation of the human beta-1, 4-galactosyltransferase V gene in cancer cells: Essential role of transcription factor Sp1. J. Biol. Chem. 2004, 279:39574-39583.
18. Sato T., Furukawa K. Sequential action of Ets-1 and Sp1 in the activation of the human beta-1, 4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells. J. Biol. Chem. 2007, 282:27702-27712.
19. Sato T., et al. Molecular cloning of a human cDNA encoding beta-1, 4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc beta-1, 4-galactosyltransferase. Proc. Natl. Acad. Sci. USA 1998, 95:472-477.
20. Sato T., et al. Correlated gene expression between beta-1, 4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines. Biochem. Biophys. Res. Commun. 2000, 276:1019-1023.
21. Sato T., et al. Occurrence of poly-N-acetyllactosamine synthesis in Sf-9 cells upon transfection of individual human beta-1, 4-galactosyltransferase I, II, III, IV, V and VI cDNAs. Biochimie 2001, 83:719-725.
22. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2001, 2:827-837.
23. Shi Q., et al. Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J. Biol. Chem. 2004, 279:52200-52209.
24. Shirane K., et al. Involvement of beta-1, 4-galactosyltransferase V in malignant transformation-associated changes in glycosylation. Biochem. Biophys. Res. Commun. 1999, 265:434-438.
25. Stiles C.D., Rowitch D.H. Glioma stem cells: A midterm exam. Neuron 2008, 58:832-846.
26. Xu S., et al. Over-expression of beta-1, 4-galactosyltransferase I, II, and V in human astrocytoma. J. Cancer Res. Clin. Oncol. 2001, 127:502-506.
27. Zheng X.L., et al. Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. J. Biol. Chem. 2001, 276:13822-13829.